Mark Shirtliff - Publications

Affiliations: 
Molecular Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Microbiology Biology

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Freiberg JA, Le Breton Y, Harro JM, Allison DL, McIver KS, Shirtliff ME. The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated Streptococcus pyogenes Infections. Mbio. 11. PMID 32636245 DOI: 10.1128/mBio.00919-20  0.418
2020 Brao KJ, Wille BP, Lieberman J, Ernst RK, Shirtliff ME, Harro JM. -transgenic BALB/c mice as a model of infections of the cystic fibrosis lung. Infection and Immunity. PMID 32631918 DOI: 10.1128/Iai.00237-20  0.384
2020 Harro JM, Shirtliff ME, Arnold W, Kofonow JM, Dammling C, Achermann Y, Brao K, Parvizi J, Leid JG. Development of a Novel and Rapid Antibody-based Diagnostic for Chronic Infections Based on Biofilm Antigens. Journal of Clinical Microbiology. PMID 32051263 DOI: 10.1128/Jcm.01414-19  0.386
2020 Natoli RM, Harro J, Shirtliff M. Non–culture-based Methods to Aide in the Diagnosis of Implant-associated Infection After Fracture Surgery Techniques in Orthopaedics. 35: 91-99. DOI: 10.1097/Bto.0000000000000410  0.347
2019 Harro JM, Achermann Y, Freiberg JA, Allison DL, Brao KJ, Marinos DP, Sanjari S, Leid JG, Shirtliff ME. Clearance of from Models of Chronic Infection by Immunization Requires Both Planktonic and Biofilm Antigens. Infection and Immunity. PMID 31712267 DOI: 10.1128/IAI.00586-19  0.434
2019 Allison DL, Scheres N, Willems HME, Bode CS, Krom BP, Shirtliff ME. The Host Immune System Facilitates Disseminated Disease Due to Phagocytic Attraction to During Co-infection: A Case of Bait and Switch. Infection and Immunity. PMID 31451623 DOI: 10.1128/IAI.00137-19  0.398
2019 Khan MM, Chattagul S, Tran BQ, Freiberg JA, Nita-Lazar A, Shirtliff ME, Sermswan RW, Ernst RK, Goodlett DR. Temporal proteomic profiling reveals changes that support Burkholderia biofilms. Pathogens and Disease. PMID 30759239 DOI: 10.1093/Femspd/Ftz005  0.304
2018 Hovis JP, Montalvo R, Marinos D, Joshi M, Shirtliff M, Manson TT, O'Toole RV. Intraoperative Vancomycin Powder Reduces Staphylococcus aureus Surgical Site Infections and Biofilm Formation on Fixation Implants in a Rabbit Model. Journal of Orthopaedic Trauma. PMID 29401093 DOI: 10.1097/BOT.0000000000001136  0.359
2017 Meeker DG, Wang T, Harrington WN, Zharov VP, Johnson SA, Jenkins SV, Oyibo SE, Walker CM, Mills WB, Shirtliff ME, Beenken KE, Chen J, Smeltzer MS. Versatility of Targeted Antibiotic-loaded Gold Nanoconstructs for the Treatment of Biofilm-associated Bacterial Infections. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 1-34. PMID 29025325 DOI: 10.1080/02656736.2017.1392047  0.33
2017 Blanchette KA, Prabhakara R, Shirtliff ME, Wenke JC. Inhibition of fracture healing in the presence of contamination by Staphylococcus aureus: Effects of growth state and immune response. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 28387956 DOI: 10.1002/Jor.23573  0.7
2016 Archer NK, Adappa ND, Palmer JN, Cohen NA, Harro JM, Lee SK, Miller LS, Shirtliff ME. IL-17A and IL-17F are critical for antimicrobial peptide production and clearance of Staphylococcus aureus nasal colonization. Infection and Immunity. PMID 27736775 DOI: 10.1128/Iai.00596-16  0.52
2016 Maldarelli GA, Piepenbrink KH, Scott AJ, Freiberg JA, Song Y, Achermann Y, Ernst RK, Shirtliff ME, Sundberg EJ, Donnenberg MS, von Rosenvinge EC. Type IV pili promote early biofilm formation by Clostridium difficile. Pathogens and Disease. PMID 27369898 DOI: 10.1093/Femspd/Ftw061  0.326
2016 Allison DL, Willems HM, Jayatilake JA, Bruno VM, Peters BM, Shirtliff ME. Candida-Bacteria Interactions: Their Impact on Human Disease. Microbiology Spectrum. 4. PMID 27337476 DOI: 10.1128/microbiolspec.VMBF-0030-2016  0.345
2015 Parvizi J, Alijanipour P, Barberi EF, Hickok NJ, Phillips KS, Shapiro IM, Schwarz EM, Stevens MH, Wang Y, Shirtliff ME. Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections. The Journal of the American Academy of Orthopaedic Surgeons. 23: S32-43. PMID 25808968 DOI: 10.5435/Jaaos-D-14-00455  0.451
2015 Achermann Y, Tran B, Kang M, Harro JM, Shirtliff ME. Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model. Clinical and Vaccine Immunology : Cvi. 22: 467-76. PMID 25694647 DOI: 10.1128/Cvi.00760-14  0.426
2015 Kong EF, Kucharíková S, Van Dijck P, Peters BM, Shirtliff ME, Jabra-Rizk MA. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease. Infection and Immunity. 83: 604-13. PMID 25422264 DOI: 10.1128/IAI.02843-14  0.4
2015 Parker AC, Beenken KE, Jennings JA, Hittle L, Shirtliff ME, Bumgardner JD, Smeltzer MS, Haggard WO. Characterization of local delivery with amphotericin B and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 33: 439-47. PMID 25408519 DOI: 10.1002/Jor.22760  0.344
2015 Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology (Reading, England). 161: 168-81. PMID 25332378 DOI: 10.1099/mic.0.083485-0  0.391
2015 Jarrett AM, Cogan NG, Shirtliff ME. Modelling the interaction between the host immune response, bacterial dynamics and inflammatory damage in comparison with immunomodulation and vaccination experiments Mathematical Medicine and Biology. 32: 285-306. DOI: 10.1093/Imammb/Dqu008  0.384
2014 McConoughey SJ, Howlin R, Granger JF, Manring MM, Calhoun JH, Shirtliff M, Kathju S, Stoodley P. Biofilms in periprosthetic orthopedic infections. Future Microbiology. 9: 987-1007. PMID 25302955 DOI: 10.2217/Fmb.14.64  0.542
2014 Freiberg JA, McIver KS, Shirtliff ME. In vivo expression of Streptococcus pyogenes immunogenic proteins during tibial foreign body infection. Infection and Immunity. 82: 3891-9. PMID 25001603 DOI: 10.1128/IAI.01831-14  0.391
2014 Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clinical Microbiology Reviews. 27: 419-40. PMID 24982315 DOI: 10.1128/CMR.00092-13  0.421
2014 Arnold WV, Shirtliff ME, Stoodley P. Bacterial biofilms and periprosthetic infections. Instructional Course Lectures. 63: 385-91. PMID 24720323  0.44
2014 Sternberg C, Bjarnsholt T, Shirtliff M. Methods for dynamic investigations of surface-attached in vitro bacterial and fungal biofilms. Methods in Molecular Biology (Clifton, N.J.). 1147: 3-22. PMID 24664822 DOI: 10.1007/978-1-4939-0467-9_1  0.351
2014 Achermann Y, Kerns P, Shirtliff ME. In vivo infection studies Biomaterials and Medical Device - Associated Infections. 47-70. DOI: 10.1533/9780857097224.1.47  0.388
2014 Fox-Moon SM, Shirtliff ME. Urinary Tract Infections Caused by Proteus mirabilis Molecular Medical Microbiology: Second Edition. 3: 1389-1400. DOI: 10.1016/B978-0-12-397169-2.00077-9  0.428
2013 Arnold WV, Shirtliff ME, Stoodley P. Bacterial biofilms and periprosthetic infections. The Journal of Bone and Joint Surgery. American Volume. 95: 2223-9. PMID 24498639  0.456
2013 Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. Plos One. 8: e63040. PMID 23658662 DOI: 10.1371/journal.pone.0063040  0.735
2013 Chen Q, Dintaman J, Lees A, Sen G, Schwartz D, Shirtliff ME, Park S, Lee JC, Mond JJ, Snapper CM. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine. Infection and Immunity. 81: 2554-61. PMID 23649092 DOI: 10.1128/Iai.00271-13  0.303
2013 Archer NK, Harro JM, Shirtliff ME. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infection and Immunity. 81: 2070-5. PMID 23529621 DOI: 10.1128/IAI.00084-13  0.555
2013 Stoodley P, Hall-Stoodley L, Costerton B, DeMeo P, Shirtliff M, Gawalt E, Kathju S. Biofilms, Biomaterials, and Device-Related Infections Handbook of Polymer Applications in Medicine and Medical Devices. 77-101. DOI: 10.1016/B978-0-323-22805-3.00005-0  0.369
2012 Peters BM, Ovchinnikova ES, Krom BP, Schlecht LM, Zhou H, Hoyer LL, Busscher HJ, van der Mei HC, Jabra-Rizk MA, Shirtliff ME. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p Microbiology (United Kingdom). 158: 2975-2986. PMID 22918893 DOI: 10.1099/Mic.0.062109-0  0.335
2012 Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis and human disease. Clinical Microbiology Reviews. 25: 193-213. PMID 22232376 DOI: 10.1128/CMR.00013-11  0.396
2011 Prabhakara R, Harro JM, Leid JG, Keegan AD, Prior ML, Shirtliff ME. Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infection and Immunity. 79: 5010-8. PMID 21947772 DOI: 10.1128/Iai.05571-11  0.735
2011 Jacobsen SM, Shirtliff ME. Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence. 2: 460-5. PMID 21921687 DOI: 10.4161/viru.2.5.17783  0.59
2011 Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2: 445-59. PMID 21921685 DOI: 10.4161/viru.2.5.17724  0.601
2011 Prabhakara R, Harro JM, Leid JG, Harris M, Shirtliff ME. Murine immune response to a chronic Staphylococcus aureus biofilm infection. Infection and Immunity. 79: 1789-96. PMID 21282411 DOI: 10.1128/Iai.01386-10  0.742
2011 Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infection and Immunity. 79: 1797-803. PMID 21220484 DOI: 10.1128/IAI.00451-10  0.413
2011 Shirtliff ME, O'May GA, Brady RA, Prior ML, Leid JG. Novel vaccine strategies and improved diagnostics for musculoskeletal infections European Cells and Materials. 21: 22.  0.319
2010 Miclau T, Schmidt AH, Wenke JC, Webb LX, Harro JM, Prabhakara R, Shirtliff ME. Infection. Journal of Orthopaedic Trauma. 24: 583-6. PMID 20736799 DOI: 10.1097/BOT.0b013e3181eebf12  0.712
2010 Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME. Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms. Fems Immunology and Medical Microbiology. 59: 493-503. PMID 20608978 DOI: 10.1111/j.1574-695X.2010.00710.x  0.35
2010 Harro JM, Peters BM, O'May GA, Archer N, Kerns P, Prabhakara R, Shirtliff ME. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. Fems Immunology and Medical Microbiology. 59: 306-23. PMID 20602638 DOI: 10.1111/J.1574-695X.2010.00708.X  0.713
2009 Calhoun JH, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Seminars in Plastic Surgery. 23: 59-72. PMID 20567728 DOI: 10.1055/S-0029-1214158  0.387
2009 Unnanuntana A, Bonsignore L, Shirtliff ME, Greenfield EM. The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. An in vitro study. The Journal of Bone and Joint Surgery. American Volume. 91: 2683-92. PMID 19884443 DOI: 10.2106/Jbjs.H.01699  0.383
2009 Leid JG, Kerr M, Selgado C, Johnson C, Moreno G, Smith A, Shirtliff ME, O'Toole GA, Cope EK. Flagellum-mediated biofilm defense mechanisms of Pseudomonas aeruginosa against host-derived lactoferrin. Infection and Immunity. 77: 4559-66. PMID 19651866 DOI: 10.1128/Iai.00075-09  0.386
2009 O'May GA, Jacobsen SM, Longwell M, Stoodley P, Mobley HL, Shirtliff ME. The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation. Microbiology (Reading, England). 155: 1523-35. PMID 19372157 DOI: 10.1099/Mic.0.026500-0  0.531
2008 Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews. 21: 26-59. PMID 18202436 DOI: 10.1128/Cmr.00019-07  0.615
2008 Jacobsen SM, Lane MC, Harro JM, Shirtliff ME, Mobley HL. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. Fems Immunology and Medical Microbiology. 52: 180-93. PMID 18194341 DOI: 10.1111/J.1574-695X.2007.00358.X  0.529
2008 Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. Osteomyelitis and the role of biofilms in chronic infection. Fems Immunology and Medical Microbiology. 52: 13-22. PMID 18081847 DOI: 10.1111/j.1574-695X.2007.00357.x  0.356
2006 Jabra-Rizk MA, Shirtliff M, James C, Meiller T. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. Fems Yeast Research. 6: 1063-73. PMID 17042756 DOI: 10.1111/J.1567-1364.2006.00121.X  0.405
2006 Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infection and Immunity. 74: 3415-26. PMID 16714572 DOI: 10.1128/Iai.00392-06  0.463
2006 Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility Antimicrobial Agents and Chemotherapy. 50: 1463-1469. PMID 16569866 DOI: 10.1128/AAC.50.4.1463-1469.2006  0.355
2006 Brady RA, Leid JG, Costerton JW, Shirtliff ME. Osteomyelitis: Clinical overview and mechanisms of infection persistence Clinical Microbiology Newsletter. 28: 65-72. DOI: 10.1016/j.clinmicnews.2006.04.001  0.443
2005 Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. Journal of Immunology (Baltimore, Md. : 1950). 175: 7512-8. PMID 16301659 DOI: 10.4049/Jimmunol.175.11.7512  0.358
2003 Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. The Journal of Clinical Investigation. 112: 1466-77. PMID 14617746 DOI: 10.1172/Jci20365  0.461
2002 Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infection and Immunity. 70: 6339-45. PMID 12379713 DOI: 10.1128/IAI.70.11.6339-6345.2002  0.404
2002 Shirtliff ME, Mader JT. Acute septic arthritis. Clinical Microbiology Reviews. 15: 527-44. PMID 12364368 DOI: 10.1128/Cmr.15.4.527-544.2002  0.324
2002 Leid JG, Costerton JW, Shirtliff ME, Gilmore MS, Engelbert M. Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. Dna and Cell Biology. 21: 405-13. PMID 12167243 DOI: 10.1089/10445490260099692  0.421
2002 Shirtliff ME, Calhoun JH, Mader JT. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clinical Orthopaedics and Related Research. 239-47. PMID 12151901 DOI: 10.1097/00003086-200208000-00027  0.301
2001 Shirtliff ME, Calhoun JH, Mader JT. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. The Journal of Antimicrobial Chemotherapy. 48: 253-8. PMID 11481297 DOI: 10.1093/Jac/48.2.253  0.351
2000 Balaban N, Collins LV, Cullor JS, Hume EB, Medina-Acosta E, Vieira da Motta O, O'Callaghan R, Rossitto PV, Shirtliff ME, Serafim da Silveira L, Tarkowski A, Torres JV. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP Peptides. 21: 1301-1311. PMID 11072116 DOI: 10.1016/S0196-9781(00)00272-2  0.329
1999 Mader JT, Shirtliff M, Calhoun JH. The host and the skeletal infection: classification and pathogenesis of acute bacterial bone and joint sepsis. Bailliã¨Re's Best Practice & Research. Clinical Rheumatology. 13: 1-20. PMID 10952846 DOI: 10.1053/Berh.1999.0003  0.399
1999 Mader JT, Shirtliff ME, Bergquist SC, Calhoun J. Antimicrobial treatment of chronic osteomyelitis. Clinical Orthopaedics and Related Research. 47-65. PMID 10101310 DOI: 10.1097/00003086-199903000-00008  0.363
1999 Shirtliff ME, Mader JT, Calhoun J. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Clinical Orthopaedics and Related Research. 229-36. PMID 10078148 DOI: 10.1097/00003086-199902000-00026  0.311
Show low-probability matches.